Categories News Press Releases Archives 2026 June May April March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January Nov 03 U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) Read More